Category Specific RSS

ptsd

Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial

Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…

1 year ago

Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme

In July last year, Australia became the first country to legalise ecstasy (MDMA) and magic mushrooms (psilocybin) for mental health…

1 year ago

TGA gives green light to Emyria’s psychiatrists for MDMA therapy for PTSD

Mental health treatment provider Emyria (ASX: EMD) has announced that its psychiatry specialist has been granted "Authorised Prescriber" status by…

2 years ago

Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD

In Australia, about 43% of people aged between 16 and 85 had experienced a mental disorder at some point as…

2 years ago

Incannex set to start psychedelic-assisted PTSD treatment in September after TGA approval

Health experts in Australia believe that around 12% of Australians will experience PTSD (post-traumatic stress disorder) at some point in…

2 years ago

Emyria recruits first patient for its meth-assisted therapy to treat PTSD

As news of billionaire (and controversial) business magnate Elon Musk taking “microdoses of ketamine (a dissociative drug)” to manage depression…

2 years ago